Crystal Pharmatech Overview

  • Founded
  • 2010

Founded
  • Status
  • Private

  • Employees
  • 180

Employees
  • Latest Deal Type
  • IPO

  • (Cancelled)
  • Latest Deal Amount
  • $92.8M

  • Investors
  • 5

Crystal Pharmatech General Information

Description

Developer and provider of solid-state chemistry services intended to focus on material science and engineering for drug development. The company's services include a range of services form screening and evaluation to processing for active pharmaceutical ingredients and formulations, enabling pharmaceutical industries to develop new drugs efficiently.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Laboratory Services (Healthcare)
Primary Office
  • Suite B4-101, 218 Xinghu Street
  • Suzhou Industrial Park
  • Suzhou, Jiangsu 215123
  • China
+86 0512 0000 0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Crystal Pharmatech Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. IPO 02-Oct-2021 $92.8M 00000 Cancelled Generating Revenue
6. Secondary Transaction - Private 09-Mar-2020 00.000 000.00 Completed Generating Revenue
5. Later Stage VC (Series B) 07-Nov-2018 000.00 000.00 00000 Completed Generating Revenue
4. Later Stage VC 02-Jan-2018 000.00 000.00 00.000 Completed Generating Revenue
3. Later Stage VC 06-Nov-2017 00000 000.00 00.000 Completed Generating Revenue
2. Later Stage VC 18-Sep-2017 $5.38M $15.4M 000.00 Completed Generating Revenue
1. Later Stage VC (Series A) 16-Sep-2015 $10M $10M Completed Generating Revenue
To view Crystal Pharmatech’s complete valuation and funding history, request access »

Crystal Pharmatech Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer and provider of solid-state chemistry services intended to focus on material science and engineering for drug
Drug Discovery
Suzhou, China
180 As of 2019
000.00
0000 0000-00-00
00000000

000000

amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqu
000000000000000
Beijing, China
00000 As of 0000
00000
000000000 00000

000000

equat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla
0000 000000000
Hyderabad, India
0000 As of 0000
0000
00 0000-00-00
00000000000 0000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Crystal Pharmatech Competitors (28)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Pharmaron Formerly VC-backed Beijing, China 00000 00000 000000000 00000
000000 Private Equity-Backed Hyderabad, India 0000 0000 00000000000 0000
0000000 Private Equity-Backed Ann Arbor, MI 00000 0000000 0000
0 000000000000 Venture Capital-Backed Cincinnati, OH 000 00000 00000
0000000 0000000000 Private Equity-Backed Newton, MA 00000 00000 000000000 00000
You’re viewing 5 of 28 competitors. Get the full list »

Crystal Pharmatech Patents

Crystal Pharmatech Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20220204519-A1 Crystal form of upadacitinib, preparation method therefor, and use thereof Pending 08-Jul-2020 0000000000 0
US-20220324808-A1 Co-crystal of compound i dihydrochloride and preparation method and use thereof Pending 03-Jan-2020 0000000000
US-20220372021-A1 Resmetirom crystal, preparation method for same, and uses thereof Pending 26-Dec-2019 0000000000
US-20210363116-A1 Crystal form of tafamidis and preparation method therefor and use thereof Pending 15-Nov-2019 0000000000
EP-4059926-A1 Crystal form of tafamidis and preparation method therefor and use thereof Pending 15-Nov-2019 C07D263/57 0
To view Crystal Pharmatech’s complete patent history, request access »

Crystal Pharmatech Executive Team (2)

Name Title Board Seat Contact Info
Minhua Chen Ph.D Co-Founder & Chief Executive Officer
Yanfeng Zhang Ph.D Co-Founder & Chief Scientific Officer
To view Crystal Pharmatech’s complete executive team members history, request access »

Crystal Pharmatech Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Crystal Pharmatech Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Junshang Capital Venture Capital Minority 000 0000 000000 0
Cowin Capital Venture Capital Minority 000 0000 000000 0
Oriza Holdings Asset Manager Minority 000 0000 000000 0
Shiyu Capital Venture Capital Minority 000 0000 000000 0
Renren Corporation Minority 000 0000 000000 0
To view Crystal Pharmatech’s complete investors history, request access »

Crystal Pharmatech Investments (4)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000000 000000 30-Jun-2021 0000 00000 000.00 Drug Discovery
000000 00000 01-Feb-2021 000000000 Pharmaceuticals
0000000 18-Apr-2018 00000 0000 000.00 Pharmaceuticals
F&S Pharmatech 21-Oct-2015 Corporate Pharmaceuticals 000000 00
To view Crystal Pharmatech’s complete investments history, request access »